Drug intelligence / Profile preview

thioacetamide

Development stage
Discontinued
Modality
Small Molecules
Administration
Animal Injection, Animal Feed, Laboratory Use (not For Therapeutic Administration In Humans)
01

Overview

**Thioacetamide** is a small molecule organosulfur compound with the formula C₂H₅NS, best known as a potent hepatotoxin. In biomedical research, thioacetamide is commonly used to induce acute and chronic liver injury—such as fibrosis and cirrhosis—in animal models, mimicking features of human liver disease[2][3][5][7]. Its toxicity arises from metabolic activation by cytochrome P450 enzymes to reactive intermediates (*S*-oxide and *S,S*-dioxide) that covalently bind to cellular proteins and lipids, causing oxidative stress, hepatocellular necrosis, apoptosis, and organ damage[1][4][5][7]. Thioacetamide is classified as a possible human carcinogen (IARC Group 2B)[2][6][8]. It is not an approved therapeutic agent and is used primarily as a laboratory reagent and tool compound.

Other names
ethanethioamideacetothioamidethiacetamidethioacetamid
02

Targets

CYP3A4 (Cytochrome P450 3A4)CYP1A2 (Cytochrome P450 1A2)CYP2E1

Beyond the preview

Go deeper on thioacetamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on thioacetamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call